CY1110717T1 - Ενα πρωτοτυπο συστημα χορηγησης φαρμακου για τους αναστολεις αντλιας πρωτονιων και τις διαδικασιες τους - Google Patents

Ενα πρωτοτυπο συστημα χορηγησης φαρμακου για τους αναστολεις αντλιας πρωτονιων και τις διαδικασιες τους

Info

Publication number
CY1110717T1
CY1110717T1 CY20101100704T CY101100704T CY1110717T1 CY 1110717 T1 CY1110717 T1 CY 1110717T1 CY 20101100704 T CY20101100704 T CY 20101100704T CY 101100704 T CY101100704 T CY 101100704T CY 1110717 T1 CY1110717 T1 CY 1110717T1
Authority
CY
Cyprus
Prior art keywords
protton
procedures
drug administration
administration system
original drug
Prior art date
Application number
CY20101100704T
Other languages
English (en)
Inventor
Mannalal Ramgopal Bajaj
Rajan Shantaram Samant
Bharat Babulal Shah
Original Assignee
Lyka Labs Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34746668&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1110717(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lyka Labs Limited filed Critical Lyka Labs Limited
Publication of CY1110717T1 publication Critical patent/CY1110717T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)

Abstract

Η παρούσα εφεύρεση κοινοποιεί ένα πρωτότυπο σύστημα χορήγησης φαρμάκου για αναστολείς της αντλίας πρωτονίων, το οποίο περιλαμβάνει ενώσεις βενζιμιδαζολίου ή τα άλατα των ενώσεων αυτών, κατά προτίμηση τη Ραβεπραζόλη ή τα άλατα αυτής, καθώς επίσης και φαρμακευτικά αποδεκτά έκδοχα, σε μορφή κόνεως, η οποία μπορεί να ανασυσταθεί σε έναν αποδεκτό για παρεντερική χορήγηση διαλύτη, ώστε να σχηματιστεί ένα ενέσιμο διάλυμα.
CY20101100704T 2003-11-05 2010-07-27 Ενα πρωτοτυπο συστημα χορηγησης φαρμακου για τους αναστολεις αντλιας πρωτονιων και τις διαδικασιες τους CY1110717T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1164MU2003 2003-11-05
EP04820975A EP1713476B1 (en) 2003-11-05 2004-11-03 Process for the preparation of benzimidazoles

Publications (1)

Publication Number Publication Date
CY1110717T1 true CY1110717T1 (el) 2015-06-10

Family

ID=34746668

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100704T CY1110717T1 (el) 2003-11-05 2010-07-27 Ενα πρωτοτυπο συστημα χορηγησης φαρμακου για τους αναστολεις αντλιας πρωτονιων και τις διαδικασιες τους

Country Status (11)

Country Link
US (1) US20070014875A1 (el)
EP (1) EP1713476B1 (el)
AT (1) ATE466579T1 (el)
BR (1) BRPI0416027A (el)
CY (1) CY1110717T1 (el)
DE (1) DE602004027088D1 (el)
DK (1) DK1713476T3 (el)
ES (1) ES2344905T3 (el)
PL (1) PL1713476T3 (el)
PT (1) PT1713476E (el)
WO (1) WO2005065682A2 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007129961A1 (en) * 2006-05-09 2007-11-15 Astrazeneca Ab Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation
CN102138907A (zh) * 2010-02-02 2011-08-03 南京长澳医药科技有限公司 一种稳定的雷贝拉唑钠冻干制剂及其制备方法
CN103463636B (zh) * 2013-09-17 2015-05-27 天津市嵩锐医药科技有限公司 一种供注射用的泮托拉唑钠药物组合物
MA41623A (fr) * 2015-11-26 2018-01-09 Verano Ilac Sanayi Ve Ticaret A S Composition lyophilisée de composé de benzimidazole

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994002414A1 (en) * 1992-07-20 1994-02-03 Unilever Plc Manufacture of gas hydrates
WO1994002141A1 (en) * 1992-07-28 1994-02-03 Astra Aktiebolag Injection and injection kit containing omeprazole and its analogs
TW280770B (el) * 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
CA2419067C (en) * 2000-08-18 2008-12-23 Takeda Chemical Industries, Ltd. Injectable composition comprising benzimidazole compound and strong alkali

Also Published As

Publication number Publication date
WO2005065682A3 (en) 2005-09-01
PT1713476E (pt) 2010-08-04
US20070014875A1 (en) 2007-01-18
ATE466579T1 (de) 2010-05-15
WO2005065682A2 (en) 2005-07-21
ES2344905T3 (es) 2010-09-09
EP1713476A2 (en) 2006-10-25
DK1713476T3 (da) 2010-08-09
EP1713476B1 (en) 2010-05-05
BRPI0416027A (pt) 2007-01-02
DE602004027088D1 (de) 2010-06-17
PL1713476T3 (pl) 2010-10-29

Similar Documents

Publication Publication Date Title
CY1121125T1 (el) Συνθεσεις για τη θεραπευτικη αντιμετωπιση του πονου και/ή της φλεγμονης
CY1120564T1 (el) Υδατικα εναιωρηματα tmc278
NO20071914L (no) Kontrollert avleveringssystem
CY1119381T1 (el) Παραγωγα 2-μεθυλομορφολινο πυριδο-, πυραζο- και πυριμιδο-πυριμιδινης ως αναστολεις mtor
DE602004027936D1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
DK0991407T3 (da) Stabilisering af syresensitive benzimidazoler med amino/cyclodextrin-kombinationer
CY1115176T1 (el) Ρυθμιστες υποδοχεων τυπου toll
EA201070167A1 (ru) Замещенные производные индазола, активные как ингибиторы киназы
ECSP066950A (es) Combinaciones de glicopirrolato y agonistas del adrenoceptor-beta2
RS52367B (en) GLATIRAMER ACETATE FORMULATION FORMATED VOLUMES AND APPLICATION PROCEDURES
CY1112860T1 (el) 5-υποκατεστημενα παραγωγα κιναζολινονης ως αντικαρκινικοι παραγοντες
EA200870545A1 (ru) Новые гетероциклические соединения
SE0402762D0 (sv) Indazole sulphonamide derivatives
CY1111442T1 (el) Ενωσεις πιπεριδινης και χρησεις αυτων
MX2008013040A (es) Derivados de bencimidazol 5-sulfonamida como ligandos del receptor cannabinoide 1.
NO20082097L (no) Farmasoytiske sammensetninger
CY1110717T1 (el) Ενα πρωτοτυπο συστημα χορηγησης φαρμακου για τους αναστολεις αντλιας πρωτονιων και τις διαδικασιες τους
BRPI0415053B8 (pt) inibidor de glicoproteína-p, método para preparar o mesmo e composição farmacêutica que compreende o mesmo
NO20055207L (no) Oralt farmasoytisk preparat for protonpumpeantagonister
AR057885A1 (es) Acido 1-(1-(2- etoxietil) - 1- etil-7-(4- metilpiridin -2- ilamino)- 1h pirazolo (4,3-d) pirimidin -5- il) piperidina -4- carboxilico y las sales del mismo. composiciones farmaceuticas.
ITMI20041245A1 (it) Composizioni farmaceutiche iniettabnili comprendenti diclofenac sodico e b-ciclodestrina
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
TN2010000008A1 (en) Oral pharmaceutical solutions containing telbivudine
ATE497761T1 (de) Therapeutisches oder prophylaktisches mittel gegen leukämie
HRP20070081T3 (en) Nasal pharmaceutical composition of piribedil